"Chemotherapy, Adjuvant" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drug therapy given to augment or stimulate some other form of treatment such as surgery or radiation therapy. Adjuvant chemotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.
| Descriptor ID |
D017024
|
| MeSH Number(s) |
E02.186.170 E02.319.170
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Chemotherapy, Adjuvant".
Below are MeSH descriptors whose meaning is more specific than "Chemotherapy, Adjuvant".
This graph shows the total number of publications written about "Chemotherapy, Adjuvant" by people in this website by year, and whether "Chemotherapy, Adjuvant" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 3 | 3 |
| 1995 | 0 | 4 | 4 |
| 1996 | 0 | 10 | 10 |
| 1997 | 0 | 8 | 8 |
| 1998 | 0 | 3 | 3 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 4 | 4 |
| 2001 | 4 | 9 | 13 |
| 2002 | 2 | 3 | 5 |
| 2003 | 0 | 8 | 8 |
| 2004 | 2 | 9 | 11 |
| 2005 | 0 | 11 | 11 |
| 2006 | 0 | 9 | 9 |
| 2007 | 0 | 14 | 14 |
| 2008 | 2 | 18 | 20 |
| 2009 | 0 | 16 | 16 |
| 2010 | 0 | 17 | 17 |
| 2011 | 0 | 19 | 19 |
| 2012 | 0 | 13 | 13 |
| 2013 | 0 | 12 | 12 |
| 2014 | 5 | 5 | 10 |
| 2015 | 1 | 12 | 13 |
| 2016 | 1 | 15 | 16 |
| 2017 | 3 | 15 | 18 |
| 2018 | 0 | 19 | 19 |
| 2019 | 7 | 14 | 21 |
| 2020 | 2 | 5 | 7 |
| 2021 | 2 | 5 | 7 |
| 2022 | 1 | 9 | 10 |
| 2023 | 0 | 3 | 3 |
| 2024 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemotherapy, Adjuvant" by people in Profiles.
-
Editorial Comment on "Social Vulnerability and Receipt of Neoadjuvant Chemotherapy in Patients Undergoing Radical Cystectomy for Bladder Cancer". Urology. 2024 Sep; 191:85.
-
Improved Survival With Adjuvant Cyclooxygenase 2 Inhibition in PIK3CA-Activated Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance). J Clin Oncol. 2024 Aug 20; 42(24):2853-2859.
-
Neoadjuvant and adjuvant systemic therapy in HCC: Current status and the future. Hepatol Commun. 2024 Jun 01; 8(6).
-
Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer: The Alliance A011502 Randomized Trial. JAMA. 2024 05 28; 331(20):1714-1721.
-
Validation of the RSClin risk calculator in the National Cancer Data Base. Cancer. 2024 Apr 15; 130(8):1210-1220.
-
Safety and feasibility of establishing an adjuvant hepatic artery infusion program. HPB (Oxford). 2024 May; 26(5):656-663.
-
Preoperative Treatment of Locally Advanced Rectal Cancer. N Engl J Med. 2023 Jul 27; 389(4):322-334.
-
Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials. J Clin Oncol. 2023 03 01; 41(7):1376-1382.
-
Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT. J Clin Oncol. 2023 03 01; 41(7):1370-1375.
-
Low-Intensity Adjuvant Chemotherapy for Breast Cancer in Older Women: Results From the Prospective Multicenter HOPE Trial. J Clin Oncol. 2023 01 10; 41(2):316-326.